Objectives: Galactomannan (GM) and Aspergillus DNA detection are useful tools for the diagnosis of invasive pulmonary aspergillosis (IPA), primarily in blood and bronchoscopy samples. This study aimed to evaluate the utility of both markers for detection of Aspergillus in sputum from patients with allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA). Methods: ABPA or CPA demographic patient data were retrieved. This retrospective observational audit included 159 patients with at least one sputum pair. 223 sputum sample pairs were analysed, as well as six control samples for GM only. Real time PCR was performed following sputum DNA extraction using the MycAssay™ Aspergillus kit and cycle thresholds were subtracted from 38 to give positive values (transformed Ct, TCt). Results: The mean age of the patients was 61.81 years (SD: ± 11.06; range 29-100). One hundred and twentysix (79.2%) had CPA. Cultures were positive for fungi in 13.1% of the samples, and A. fumigatus was the commonest (11.9%) fungus isolated. Receiver operating characteristic (ROC curve) analysis of sputum GM comparing TCt of > 0.0, and > 2.0 to derive GMI cut-off values showed a cut-off of 6.5. About 50% of sputa with strongly positive PCR values had GM values > 6.5. Two of six (33%) control samples had GM indices > 6.5. Conclusion: It is not clear that GM determinations in sputum are useful for diagnosis of either CPA or ABPA, or following therapy.
Introduction
Aspergillus species may cause life-threatening respiratory infections including invasive pulmonary aspergillosis, and allergic and chronic lung disease (Hope et al., 2005) . A small number of species of Aspergillus are responsible for pulmonary aspergillosis including allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) (Hope et al., 2005; Denning et al., 2011) . While ABPA is a noninvasive form of Aspergillus lung disease with hypersensitivity manifestations in patients who have pre-existing atopy, asthma or cystic fibrosis (Kousha et al., 2011) , CPA manifests in patients who have impaired immunity and chronic obstructive pulmonary diseases (COPD) (Kousha et al., 2011) . Globally, about 6.8% of asthmatic patients and those with corticosteroid-complicated asthma develop ABPA (Agarwal et al., 2013) . Among cystic fibrosis patients, the prevalence of ABPA was found to be 2-15% (Denning et al., 2003a) , increasing to 18% among children (Sharma et al., 2014) . The global burden of CPA complicating ABPA has been estimated to be approximately 400,000 patients (Denning et al., 2013a) . Most subjects with a simple aspergilloma are asymptomatic except for haemoptysis which occurs in about 50-90% of cases (Patterson and Strek, 2014) . Confirmation of diagnosis of these infections requires assessment of clinical symptoms, positive Aspergillus spp. culture from respiratory secretions, histological demonstration of fungal invasion, detection of Aspergillus IgG antibody and other immunological tests as well as review of radiological appearances (Denning et al., 2003a; Zmeili and Soubani, 2007; Saraceno et al., 1997; Agarwal et al., 2015) .
Most diagnostic tests for the detection of Aspergillus and other fungi utilise serum and bronchoalveolar lavage (BAL) fluid for the confirmation of pulmonary aspergillosis and acute invasive aspergillosis (Agarwal et al., 2015) . BAL requires bronchoscopy that is invasive and may be difficult to obtain in critically ill patients . However, sputum that is either expectorated or induced is non-invasive and its diagnostic significance in term of volume yield, sensitivity and specificity cannot be overemphasized (Fraczek et al., 2014; Schelenz et al., 2015; Kimura et al., 2008) .
The detection of galactomannan (GM), a polysaccharide that is released during Aspergillus growth, is a useful and reliable non-invasive diagnostic test for screening and management of aspergillosis and is often more sensitive than culture (Schelenz et al., 2015; Fisher et al., 2013) . The level of galactomannan in body fluids such as serum and BAL is positively associated with the fungal burden of Aspergillus (Fisher et al., 2013) . Two studies have shown evaluated GM detection in sputum, one in patients with invasive aspergillosis (Kimura et al., 2009) , one in cystic fibrosis (Baxter et al., n.d.) . The optimal cut-off for the galactomannan index (GMI), as determined by constructing receiver operating characteristic (ROC) curve, and for the diagnosis of invasive pulmonary aspergillosis had been set at equal or > 0.5 for serum and 1.0 for BAL respectively (Schelenz et al., 2015; Kimura et al., 2009; Khorvash et al., 2014; Morrissey et al., 2013; He et al., 2011; Richardson and Warnock, 2012) . There have been considerable variations in the sensitivity and specificity of GMI detections in body fluids (Fisher et al., 2013) . In BAL fluid, the sensitivity ranges between 29 and 100% (Hope et al., 2005) , whilst it ranges between 17 and 100% in serum (Schelenz et al., 2015) . There is considerable controversy surrounding the optimal cut-off for respiratory secretion GMI values. A cutoff value of 1.2 in sputum was proposed for Aspergillus GM in IPA among haematological patients with sensitivity and specificity set at 100 and 62.2% respectively (Kimura et al., 2008; Kimura et al., 2009) .
Real-Time PCR (RT-PCR) has now become an important diagnostic procedure for the diagnosis of aspergillosis (Fraczek et al., 2014) . Detection of Aspergillus DNA has been applied to most body fluids including blood, BAL and sputum specimens using commercially available kits, for example MycAssay® Aspergillus (Baxter et al., 2013) (Lab21, Cambridge, UK). Both GM and Aspergillus PCR have shown higher sensitivity than culture for the detection of Aspergillus species in sputum in CF patients (Baxter et al., 2013; Baxter et al., 2011) and PCR in non-CF patients Langridge et al., 2016) . A cycle threshold (Ct) value < 36.0 is regarded as positive for Aspergillus DNA in RT-PCR in respiratory fluids (Tuon, 2007) . However, there have been many inconsistencies in the reported RT-PCR Ct and GM index values for positive detection of Aspergillus (Kimura et al., 2009) .
The survival of patients with aspergillosis is highly dependent on the ability to make an early and accurate diagnosis. Since the isolation of organisms is rarely successful, this study was designed to determine the GM index and PCR Ct values to evaluate the cut-off values for positive sputum detection of Aspergillus in patients with ABPA and CPA.
Materials and methods

Study design
The audit was a retrospective observational study involving routinely collected sputum samples from patients with ABPA and CPA, whether they have been treated or not. Baseline data for patients with a diagnosis of ABPA or CPA, as previously described Denning et al., 2003b) , were collected and included age, gender, sputum microscopy, fungal culture and current antifungal treatment. The audit was registered with the University Hospital of South Manchester audit department.
Patient selection
Patients with ABPA or CPA who had submitted sputum samples for microscopy, fungal culture, Aspergillus RT-PCR and detection of GM antigen by ELISA within a two weeks interval were identified. Approximately 60 ABPA and CPA patients attend the National Aspergillosis Centre (NAC) clinics each week, and some do not produce sputum. The pairs of values of results for GM and PCR were recorded for each patient. Unselected sputa submitted by general practitioners for routine bacterial culture were used as controls for GM only.
Laboratory procedures
The sputum samples were divided into aliquots for the routine direct microscopy, culture, galactomannan testing and RT-PCR. Consistency of sputum specimen was also graded as watery, salivary, mucoid, mucopurulent, and purulent and blood stained.
Microscopy
Sputum samples were digested with dithiothreitol (Sputasol®) (Stokell et al., 2014) and then examined under bright-field and fluorescent microscopy with calcofluor white. Aliquots of digested sputum were cultured on Sabouraud dextrose agar plates (SAB) and incubated for a total of 7 days at 30°C and 37°C (Denning et al., 2013b) . Fungal identification was determined by conventional mycological procedures, and by DNA sequencing when required Denning et al., 2003a) .
Galactomannan assay
GM levels were determined using a commercially available kit (Platelia™ Aspergillus, BIO-RAD, France). The kit has been validated only for serum and bronchoalveolar lavage (BAL). A BAL sample result that was greater than a 1.0 index value was considered to be positive while 0.5 was the validated index value for serum. However, the performance for sputum has not been validated. The results interpreted according to the manufacturer recommendations, are usually expressed as the ratio of optical densities (OD) of either serum or BAL samples to the mean cut-off of the threshold control OD.
Aspergillus PCR assay
Aspergillus spp. DNA was detected using the commercially available real-time PCR diagnostic assay MycAssay™ Aspergillus (Lab21, Cambridge, UK) kit. The control reagent was set at a cycle threshold (Ct) of 38.0. Interpretations of the Ct value according to the manufacturer guidelines indicate that a Ct value of 36.0 or below is positive while a Ct of 38.0 or greater is regarded as negative. However, based on local experience with this assay an additional interpretation is that a Ct value between 36 and 38 has been assigned as a weak positive which could represent aspergillosis or colonization. In the interpretation of the Ct values, all Ct values were subtracted from 38 to provide a positive and increasing value ('Transformed Ct '(TCt)) correlating with the strength of signal and Aspergillus load. A TCt of 0.0 is equivalent to Ct of 38.0 or above.
Statistical analysis
The data generated were sorted and coded serially. The analysis was carried out using SPSS version 17.0. Data was cleaned after entry by removing duplicated data that were misclassified as disease-type. Summary statistics for both categorical and continuous variables were estimated. Patients were selected based on their diagnosis of ABPA or CPA. Transformed Ct values were set at either > 0.0 or > 2.0 denoting the positivity of Aspergillus DNA detection while GM index cut-off values were set at 0.5-6.5. The sensitivity, specificity, positive predictive and negative predictive values were calculated for each possibility of the cut-off values. The Youden J-statistic (Youden Index (YI)), which is the maximum potential effectiveness of a biomarker was used for the comparison of the different cut-off values (Ruopp et al., 2008) , and its value ranges from 0.0-1.0. Receiver Operating Characteristics (ROC) curves were constructed to compare and generate the best cut-off values for GM index in the diagnosis of ABPA and CPA.
Results
Patient populations
During the audit period, a total of 159 patients who fulfilled the inclusion criteria and had at least one sputum sample pair tested for GM antigen and Aspergillus DNA by RT-PCR were included in the analysis. Other investigations retrieved from the database included results of direct microscopy and culture. In addition subsequent follow-up visits with paired samples (visit 2 = 39 patients; visit 3 = 13 patients; visit 4 = 4 patients) allowed a total 223 sputum samples that were processed to be analysed. The mean age of the patients was 61.8 years ± 11.1 (range 29-100). Ninety-one (57.2%) of the patients were male (Table 1) . One hundred and twenty-six patients (79.2%) were diagnosed with CPA, while 33 had ABPA. The majority of the sputum samples were muco-purulent, purulent and blood stained (69.7%), while others were mucoid and watery-salivary (Table 1) . Twenty-one (13.2%) of the sputum samples from the patients yielded a positive culture of fungi, and Aspergillus fumigatus was the commonest species isolated (11.9%). The PCR results and diagnostic accuracy of GM in CPA and ABPA patients are shown in Tables 2 & 3 and Figs. 1 & 3.
We were able to assess GM in six control samples, two of whom had COPD, three were not on antibiotics and one was on doxycycline, and background data was absent from two samples. The GMI ranged from 0.9 to 11.2 (mean 4.7). Two samples had high GMIs -one at 7.7 and one at 11.2. Correlations between the values of the two biomarkers, GM index and TCt values, are illustrated by scatter plots for all patients and each of the diseases. Fig. 1 (all patients; both blue (ABPA) and green (CPA) dots) shows a Spearman's rank correlation of 0.40. This value is a moderately positive correlation and is statistically significant (P < 0.001). When these diseases are analysed separately as shown in Fig. 1 (green (CPA) and blue (ABPA) dots), there is a moderate positive Spearman's rank correlation of 0.43 that is statistically significant (P < 0.001) for CPA, while for ABPA there is a weak positive Spearman's rank correlation of 0.27 that is not statistically significant (P = 0.14).
When TCt categories are compared with the GM index, the spread of the data is similar in each of the groups, though it is clear that the median GM value is higher in the categories with larger TCt values (Kruskal-Wallis P < 0.001). There is no perfect discrimination between the two larger TCt\groups in the median of their GM index (Fig. 3A) . The median GM index for a TCt of 0.0 was 1.85 while the median GM index values for TCt of 0.1-1.99 (weakly positive) and ≥ 2.0 are 4.68 and 6.66 respectively. The degree of positivity is directly proportional to the GM index values and the transformed cycle thresholds.
Galactomannan index and PCR results for second visit samples
Thirty-nine patients produced duplicate samples on their second visit (Supplementary data - Table S1 ). Six (15.4%) of the sputum samples from the patients yielded positive microscopy and positive culture of fungi on their second visit. The mean GM values of patients with positive microscopy and cultures was 7.96. Out of the 39 duplicate samples, fifteen (38.5%) had TCt > 0.0 in sample 1 and 20 (51.3%) in sample 2 while 12 (30.8%) had TCt > 2.0 in sample 1 and 13 (33.3%) in sample 2. For the GMI values, thirty-two (82.1%) had GM > 0.5 in sample 1 and 36 (92.3%) in sample 2 while 13 (33.3%) had GM ≥ 6.5 in sample 1 and 18 (46.2%) (Supplementary data -Table S2 and S3). Fig. S1 (Supplementary data) shows a non-significant (P = 0.11), weak positive Spearman's rank correlation of 0.26 between the values of GM and TCt from the second visits. There is a significant, moderate positive Spearman's rank correlation of 0.54 between the Tct for the 1st and 2nd visits (P < 0.001) as well as a significant Pearson correlation of 0.32 between the GM for the duplicate samples in the 1st and 2nd visits (P = 0.047). There was a non-significant increase in GM between the visits, with a mean of 4.54 at the first visit and a mean of 5.91 at the second visit (paired t-test P = 0.064). There was a small, non-significant increase in the TCt values between the visits, with a median of 0 at the first visit and a median of 0.1 at the second visit (Wilcoxon signed-rank test P = 0.40).
Analysis of criteria for the detection of diseases by GM
We considered three possible constructs to define positive and negative samples to determine the cut-off for GM. The first one focused on narrow criteria for "true positive". In this case, a "true positive" was a patient with PCR TCt > 0.0, along with at least one of positive microscopy and positive culture. This was termed construct A, and 16 patients (15 CPA and 1 ABPA) were found to be truly positive based on these criteria, and 143 negative. For this construct, the area under the ROC curve was 0.732 (Fig. 2) . The second construct (B) was the same as construct A regarding a "true positive" except that the PCR TCt > 2.0 and 14 patients (13 CPA and 01 ABPA) were positive. For this construct the area under the ROC curve was 0.757 (Fig. 2) . The third construct for GM analysis that was considered as "true negative" included only those samples in which microscopy and culture were negative with a PCR TCt of 0.0. In this construct, eighty-seven patients were truly negative and the area under the ROC curve was 0.729.
However, there were a few patients who were considered to be negative but had some combination of positive microscopy, positive culture and PCR TCt that resulted in them not being classified as a "true positive" or a "true negative". These categories of patients (56 patients from 159 samples in construct A and 58 patients from 159 samples in construct B) were considered as intermediates (Supplementary data, Table S4 ).
Construction of ROC curves to determine cut-off value
The optimal cut-offs for both the GM and PCR TCt values for the sputum specimens were determined by the construction of ROC curves (Fig. 2) for all patients and their clinical diagnosis. The best possible cut-off for both A and B constructs was a GMI of 6.5. At this cut-off, the sensitivity and specificity of sputum GM were 68.8% and 79.7% for construct A while it was 71.4% and 79.7% respectively for construct B. The Youden Index (J) for both A and B are 0.49 and 0.507 respectively (Table 3) . If a cut-off level of 1.0 was considered, the sensitivity and specificity would be 87.5% and 31.5% for construct A while construct B would be 92.9% and 31.7% respectively. With the "true negative", the optimal cut-off was considered to be 4.5 from the ROC. The sensitivity, specificity and Youden Index were 59.7%, 79.3% and 0.39 respectively (Table 3 and Fig. 2.) . When the category of patients considered as intermediates were analysed using the GMI cut-off value of 6.5, twenty (35.7%) of them were 'positive. ' A GMI of 6.5 was still the best possible cut-off for both A and B constructs for the duplicate sputum specimens at the second visit but with lower specificities. At this cut-off value, the sensitivity and specificity of sputum GM were 80.0% and 58.8%. for construct A whereas it was 100.0% and 58.3% respectively for construct B. Two of six control samples were positive using this cut-off, confirming poor specificity. The sensitivity and specificity of sputum GM for the 3rd visits were 100.0% and 72.7% for both construct A and B.
Analysis of GM index, microscopy and culture
The GMI was compared with the microscopy and culture results for all patients. The median level of GM for the patients with positive fungal culture group was 6.11, and there is a positive correlation between the two (Kruskal-Wallis P = 0.002). The GM values were relatively similar for the negative or normal flora group (median 3.23, IQR 0.69-6.22) and not done group (median 1.97, IQR 0.26-4.91), while the positive culture group had higher GM values (median 7.19, IQR 3.11-9.25) (Fig. 3B) .
There is also a statistically significant difference in the GMI between microscopy groups (Kruskal-Wallis P = 0.003). Twelve of the fifteen (80%) in the group where fungal elements were seen had a positive culture of Aspergillus spp. The samples with positive microscopy had the highest GM values (median 7.65, IQR 3.66-9.56) and the microscopynegative and not done samples had lower GM values (negative: median 3.87, IQR 0.70-6.43, not done: median 2.07, IQR 0.26-4.68) (Fig. 3C) . 
Relationship of sample characteristics, GM indices and PCR
The consistency of the sputum samples according to the Mycology Reference Centre Manchester (MRCM) classification was associated with the predictive value of the two biomarkers as evident in Table 4 . Mucopurulent, purulent and blood-stained sputa were associated with higher levels of both GMI and TCt. There was a significant association between purulent sputa and increased level of GMI and detection of (caption on next page) S. Fayemiwo et al.
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Aspergillus genomic DNA (P < 0.05). A GMI of 6.5 was associated with about 50% of strongly positive PCR values. The average mean GMI associated with mucoid, mucopurulent, purulent and blood-stained sputa was 4.93 ( Fig. 3D and E) .
Discussion
In sputum, the gold standard to confirm the presence of Aspergillus spp. remains microscopy and culture, but these methods are not highly sensitive, however positivity in microscopy and culture of sputum is not always indicative of disease (Schelenz et al., 2015) .
In our study, there was no perfect relationship between the GMI and PCR for the detection of Aspergillus in the sputum of either patients with ABPA or CPA. This is reflected in the mean GMI level of 3.81, and the mean transformed Ct of 1.49. This result does not concur with previous studies on the diagnosis of pulmonary aspergillosis that validated a GM index of 1.0 for BAL (Khorvash et al., 2014; Morrissey et al., 2013; Wichmann and Kluge, 2013) and 1.2 for sputum (16). In the present study, forty-seven (29.6%) patients had GMI < 1.0 whilst about 60.1% of them were negative for Aspergillus DNA. Even though PCR is highly sensitive and specific, most of the patients in whom Aspergillus DNA was not detected in their sputum had detectable GM, with a GMI which ranged from 2.0 to 14.0. A similar situation is seen with our 'control' samples in which 33% had high GM indices. In fact the term control is potentially misleading as GPs in the UK tend to submit samples for problematic patients and the two patients with high GM indices could have some form of pulmonary or airways aspergillosis, such as Aspergillus bronchitis. The prior study evaluating GM in sputum from patients suspected of having invasive aspergillosis indicated that GMI sensitivity may be improved by testing multiple samples and two consecutive positive GMI readings should be considered diagnostic (He et al., 2011) . It was also discovered that PCR was more sensitive than GMI in our study as confirmed by others (Fraczek et al., 2014; Buchheidt et al., 2004 ) though both biomarkers were significantly correlated.
The significance of the two biomarkers for the detection of Aspergillus antigen and DNA in the sputum of patients cannot be overemphasised. The mean GMI value was higher among CPA patients than the ABPA. This might not be unconnected with the fact that CPA is associated with lung damage and pre-existing lung diseases that allow the airway or damaged lung tissue to be colonized with Aspergillus spp. (Zmeili and Soubani, 2007; Kimura et al., 2009; Smith and Denning, 2011; Schweer et al., 2014) . ABPA, on the other hand, is characterised by intense inflammation of the airway and colonization by conidia, hyphae and hyphal fragments of Aspergillus (Shah and Panjabi, 2014; Wark, 2004 ). This fact is also supported in our study where seventeen CPA patients produced a positive sputum culture of A. fumigatus, while only three ABPA patients had positive sputum cultures. This is also in agreement with previous studies where some of the patients with Aspergillus isolation from respiratory secretions could not fulfil the diagnostic criteria of ABPA (Liu et al., 2013) . The characteristics and consistencies of sputum that have been adjudged to be a non-invasive alternative to bronchoscopy and BAL in the diagnosis of respiratory infections were studied in this audit. The sputum classification adopted by the MRCM was easier to assess and evaluate than the previous Geckler classification used in a previous study (Kimura et al., 2009 ). Most of the sputa were purulent and mucopurulent in nature. Purulent and blood stained sputum samples were significantly associated with positive cultures and strong PCR signals among CPA than ABPA patients, while GMI > 6.5 was more often positive in purulent and blood-stained samples as well as muco-purulent sputum samples. Both PCR signals and GM were usually negative in watery-salivary and mucoid samples, raising the prospect for laboratories of rejecting these samples for further analysis or at least reporting the sputum character with the result, indirectly suggesting that a negative result is a potential false negative.
Since we have no working gold standard for the diagnostic utility of GMI in our patient groups, we created three possible constructs for the analysis of GM values. Construct A "true positivity "considered TCt of > 0.0 with positive microscopy or culture while Construct B considered positivity with TCt of ≥ 2.0, in addition to positive culture or microscopy. These constructs only captured about 10% of patients and so more than 90% of the patients were negative but might reasonably considered not be "true negatives". Not all the patients who had either microscopy or culture positive were positive for both GM antigen and detection of Aspergillus DNA. These categories of patients have not been truly captured. We need further studies to be able to define the true positivity criteria for their diagnosis. We also considered "true negativity" with negative PCR, GM < 1.0 and TCt of 0.0. In this category, about 45% of patients were truly negative. With all the inconsistencies in the results of the GM and PCR, we might need further studies to validate the usefulness of measurement of GM antigen in the sputum for the screening and diagnosis of CPA or ABPA.
To minimize these effects, we constructed the ROC curve for the two constructs and true negativity to find the optimal cut-off for the positive GM. The optimal cut-off value of sputum GMI as estimated from the ROC curve for both ABPA and CPA in the two possible constructs was 6.5 (Fig. 2) . Using the cut-off value of 6.5, the sensitivity and specificity of galactomannan antigen detection were 68.8 and 79.7% for construct A and 71.4 and 79.3% for construct B respectively. However, the PPV was below 30% and the NPV were between 96 and 97% (Table 3) . This finding is in contrast with the previous study where 1.2 was the optimal cut-off for sputum in the diagnosis of IPA (Kimura et al., 2009 ). Our small 'control' group may not be true controls. Obtaining sputum from normal people, who would not naturally produce sputum, is challenging, and bronchoscopy or induced sputum samples are not a reasonable substitute for this purpose.
In this study, a GMI of 1.0 was associated with high sensitivity above 90%, specificity below 30% and higher negative predictive value. However, this cut-off couldn't have been optimal because of the lower level of Youden J Index which was < 0.2 in both constructs (Ruopp et al., 2008) . This inconsistency was also supported by varied sensitivities that ranged from 27 to 100% in serum and 60-100% in sputum (Fisher et al., 2013; Kimura et al., 2009; He et al., 2011) . The reasons for these observations might be linked to sample variability, the load of organism, other medications, antifungal resistance in the context of antifungal therapy and patient host status (Kimura et al., 2009; He et al., 2011) . In order to validate the optimal cut-off for Aspergillus GM in sputum, it is suggested that long term prospective studies involving larger populations of ABPA or CPA patients with diverse predisposing factors should be carried out. In addition to the non-invasive nature of sputum collection, a previous study had confirmed that GM could be more easily detected in sputum than in other respiratory fluids (Kimura et al., 2009) . Since there was no adequate control group in the present study, it was technically difficult to assign the optimal cut-off values for the GMI.
Aspergillus spp. especially A. fumigatus and Penicillium spp. were isolated in about 13.2% of the sputa cultured from CPA and ABPA patients in our study. We had only three culture positive sputa in ABPA patients. This rate was low compared to that found in previous studies where the culture rate from sputum was as high as 56-80% Denning et al., 2003b) . High volume culture that was adopted by the MRCM could improve significantly the yield of Aspergilli from sputum samples (Fraczek et al., 2014) . There is a positive correlation between the median GM of 6.11 and positive culture of sputum. This result supported the optimal cut-off value of 6.5 of our GM analysis. > 50% of patients with culture positive sputum had a GMI > 6.0.
A strongly positive PCR with TCt of ≥2.0 was significantly associated with positive sputum culture. A GM value of > 6.5 was strongly associated with about 50% of strongly positive PCR results. As noted previously, a few of the positive sputum cultures did not concur with the corresponding positive detection of Aspergillus DNA by PCR. Due to variability in the sensitivity of PCR and increased significance of adopting TCt of > 0.0 as weak signal of Aspergillus detection, there is a need for urgent standardization and validation of PCR tests across all laboratories as advocated by other studies Fisher et al., 2013) .
Sputum consistencies could be a good predictor of positivity for microscopy, culture, GMI values and Aspergillus detection by PCR. Mucopurulent, purulent and blood-stained sputum had higher GM and PCR values. However, our study has shown that higher mean GMI values and TCt values for PCR were significantly associated with purulent sputum samples.
In conclusion, mucopurulent, purulent and blood stained sputum had higher GM and PCR values. A GMI value of > 6.5 was associated with~50% of strongly positive PCR values. We have no control group in our study which is required for setting the optimal cut-off. There are inconsistencies for both GM and PCR, so within patient reproducibility may be problematic (data not shown). Based on the results presented in this study, it is not clear whether GM is useful in sputum for diagnosis or for following therapy given the wide range of values, which did not correspond with PCR or culture.
Future direction
To be able to have the definitive optimal cut-off value for the detection of Aspergillus DNA by PCR and galactomannan antigen, more samples are needed for both index cases and the control groups. It is not clear what the source of the GM found in such high quantities in sputum is. In the future studies, possible confounding variables such as antibiotics (piperacillin-tazobactam, ampicillin), many opportunistic fungi, some solutions containing gluconate, food containing cereals products and soya beans should be evaluated (Girmenia et al., 2007; Lescher-Bru et al., 1998) .
Limitations of the study
We didn't have an adequate control group that could have been used to set up the optimal cut-off values for both PCR and GM antigen detection on sputum. 
